The HIV DNA proviral genotyping test is not indicated for detecting acquired drug resistance caused by treatment. This method effectively detects mutations that may have existed prior to treatment. Therefore, it is recommended before switching to a new drug regimen if there is no prior genotyping result for the drugs under consideration and when the viral load is low or undetectable.




